Gout

There are 154 papers on gout in aging research: 8 trials and 95 observational studies in people, 6 in animals, 39 reviews. The newest story, Nov 10, 2026: “Six genetic sites linked to kidney function decline in Taiwan”.

Disease

154 papers study it91 findings

MeSH

16 new papers in 30 daysSee all 154 papers on gout

At a glance

Human observational studies link gout with higher mortality, accelerated biological aging, frailty, cardiovascular disease, and osteoporosis. Parkinson’s disease associations differ, with lower risk in a Swedish cohort but no clear link in another study. A human trial reports that comprehensive nursing intervention lowers gout risk in older patients with hypertension and hyperuricemia.

91 findings in 58 papers from 2015 to 2026, 13 of them since May 2026

“The proportion of patients in the experimental group who developed gout was significantly lower than that in the control group(p=0.03).”
Analysis of clinical efficacy of comprehensive nursing intervention on elderly patients with hypertension combined with hyperuricemiaPakistan journal of medical sciences2023doi:10.12669/pjms.39.6.7233
  • Human trial8
  • Humans95
  • Animals5
  • Model organisms1
  • In silico4

Interventions

4

Valsartan

no changein humans1HR 1.015

1 study
  1. Valsartan was not clearly linked with gout in humans (Newly diagnosed hypertension; combined with amlodipine; compared with non-persistent users) (HR 1.015, 95% CI 0.985–1.045).

    “valsartan showed no significant difference (HR 1.015, 95% CI 0.985–1.045)”

    HumansNewly diagnosed hypertension; combined with amlodipine; compared with non-persistent users5 years

    Risk of incident gout and major adverse cardiovascular events according to angiotensin receptor blocker type in amlodipine-based combination therapy: a nationwide cohort study

    ESC Congress 2026 abstract

More on Valsartan

Febuxostat

upin humans1

1 study
  1. Febuxostat induces gout in humans (asymptomatic hyperuricemia and chronic kidney disease) (3 events).

    “three gout attacks occurred in the normal-dose group”

    Human trialasymptomatic hyperuricemia and chronic kidney disease40 mg/day9 months

    The effect of low-dose febuxostat on arterial stiffness in elderly patients with asymptomatic hyperuricemia: A prospective, longitudinal cohort study

    Nutrition, metabolism, and cardiovascular diseases : NMCD

More on Febuxostat

Insomnia

no changein silico1OR 1.018

1 study
  1. Insomnia showed no clear effect on gout in silico (OR 1.018 (95% CI 0.912-1.136)).

    “and GT (P = 0.757, OR 95 % CI = 1.018 [0.912-1.136])”

    In silico

    Genetic causality between insomnia and specific orthopedic conditions: Insights from a two-sample Mendelian randomization study

    Experimental gerontology

More on Insomnia

Parity

no changein humans1

1 study
  1. Parity was not clearly linked with gout in humans.

    “No association between parity and gout incidence was observed.”

    Humansfemales

    Association between female reproductive factors and gout: a nationwide population-based cohort study of 1 million postmenopausal women

    Arthritis research & therapy

More on Parity

Effects

12

Gout-related mortality

no changein humans1

1 study
  1. Gout was not clearly linked with gout-related mortality in humans (AAPC +0.30% (95% CI, -0.46 to +1.07)).

    “the full-period AAPC was not significant (+0.30%; 95% confidence interval (CI), -0.46 to +1.07).”

    Humans1999-2024n = 55,721

    Trends and Disparities in Gout-Related Mortality in the United States, 1999-2024: A Multiple-Cause-of-Death and Joinpoint Regression Analysis

    Cureus

Frailty index

no changein humans1

1 study
  1. Gout was not clearly linked with frailty index in humans.

    “reverse MR analysis indicated no causality”

    Humans

    Association between frailty and gout in middle-aged and older adults: A nationwide cross-sectional and Mendelian randomization study

    Medicine

More on Frailty index

Muscle mass

downin humans1

1 study
  1. Gout is linked with lower muscle mass in humans (-6.4% to -4.1%).

    “and in women with gout, T2D, hiatus hernia, CHD, and hypertension (-6.4% to -4.1%).”

    Humansfemales

    Muscle strength and muscle mass in people with long term conditions and multimorbidity: A cross-sectional study of UK Biobank participants

    medRxivPreprint

Age-related hearing loss

no changein humans1

1 study
  1. Gout was not clearly linked with age-related hearing loss in humans (P > .05).

    “Conversely, the reverse MR investigation revealed that neither gout nor serum urate levels exerted significant impact on auditory degradation (P > .05)”

    Humans

    Mendelian randomization reveals the causal association between gout and hearing impairment in older adults

    Medicine

More on Age-related hearing loss

Fracture risk

no changein humans1RR 1.09

1 study
  1. Gout showed no clear effect on fracture risk in humans (RR 1.09, 95% CI 0.99–1.19).

    “our analysis did not detect any association between gout and fracture risk when compared with the control group (RR = 1.09, 95%CI 0.99-1.19)”

    Review

    Association between gout and the risk of osteoporosis and fractures: a meta-analysis

    Zeitschrift fur Rheumatologie

Osteoporotic fractures

no changein humans1

1 study
  1. Gout was not clearly linked with osteoporotic fractures in humans (Korean population; distal radius, hip, and spine).

    “However, no such relevance was identified between gout and incident osteoporotic fractures at any site.”

    HumansKorean population; distal radius, hip, and spine

    Potential Association of Osteoporosis and Not Osteoporotic Fractures in Patients with Gout: A Longitudinal Follow-Up Study

    Nutrients

More on Osteoporotic fractures

Parkinson's disease

no changein humans1RR 0.97

1 study
  1. Gout showed no clear effect on Parkinson's disease in humans (RR 0.97, 95% CI 0.85–1.09).

    “However, gout was not closely correlated with the risk for PD (0.97 [95% CI 0.85-1.09]).”

    Review

    Dose-response meta-analysis on urate, gout, and the risk for Parkinson's disease

    NPJ Parkinson's disease

More on Parkinson's disease

Parkinson's disease risk

no changein humans1RR 0.94

1 study
  1. Gout showed no clear effect on Parkinson's disease risk in humans (RR = 0.94, 95% CI: 0.86-1.04).

    “We found no significant association between gout and the risk of PD among both sexes (RR = 0.94, 95% CI: 0.86-1.04)”

    Review

    Association between gout and the development of Parkinson's disease: a systematic review and meta-analysis

    BMC neurology

More on Parkinson's disease risk

Telomere length

downin humans1

1 study
  1. Gout is linked with lower telomere length in humans (compared with healthy participants) (p=0.001, R2=0.01873).

    “Patients with gout demonstrated shorter telomeres (p=0.001, R2=0.01873).”

    Humanscompared with healthy participants

    Patients with gout have short telomeres compared with healthy participants: association of telomere length with flare frequency and cardiovascular disease in gout

    Annals of the rheumatic diseases

More on Telomere length

Grip strength

no changein humans1

1 study
  1. Gout was not clearly linked with grip strength in humans (P = 0.77).

    “There was no difference in grip strength by history of gout (P = 0.77).”

    Humansn = 5,819

    Physical Function, Hyperuricemia, and Gout in Older Adults

    Arthritis care & research

All 12

Associations

63

Cardiovascular disease

upin humans3HR 1.32–1.87

3 studies
  1. Gout is linked with a higher risk of cardiovascular disease in humans (HR 1.87, 95% CI 1.64-2.14).

    “CVD (1.87, 1.64-2.14)”

    Humansn = 512,724

    Hyperuricemia, gout and the associated comorbidities in China: findings from a prospective study of 0.5 million adults

    The Lancet regional health. Western Pacific

  2. Gout is associated with cardiovascular disease in humans (Primary pooled analysis comparing adults with and without gout) (HR 1.32, 95% CI 1.22–1.44).

    “Primary pooled HRs (95% CIs) were 1.32 (1.22–1.44) for overall cardiovascular disease”

    ReviewPrimary pooled analysis comparing adults with and without gout

    Association between gout and risk of cardiovascular outcomes: a systematic review and meta-analysis of cohort studies

    Frontiers in medicine

  3. Gout is associated with cardiovascular disease in humans.

    “systemic trained immunity links gout to cardiovascular disease, chronic kidney disease, and metabolic syndrome”

    Review

    Trained immunity in gout: epigenetic and metabolic reprogramming of innate immune memory

    Frontiers in immunology

More on Cardiovascular disease

SGLT2 inhibitors

downin humans3

3 studies
  1. SGLT2 inhibitors lower the risk of gout in humans (30–50% risk reduction).

    “Gout showed the most robust evidence (19 studies; median NOS 7; 30–50% risk reduction), driven by a uricosuric transporter-mediated mechanism.”

    Review

    Therapeutic Repositioning of SGLT2 Inhibitors Using Real-World Data: A Scoping Review of Emerging Indications and Rare Diseases

    Research SquarePreprint

  2. SGLT2 inhibitors lower the risk of gout in humans (patients with type 2 diabetes and gout) (12 studies).

    “The main findings included reductions in SUA levels (n = 8), incidence of gout (n = 12)”

    Reviewpatients with type 2 diabetes and gout

    Effects of SGLT2 inhibitors on gout-related and cardiometabolic outcomes in patients with type 2 diabetes mellitus: a scoping review

    Advances in rheumatology (London, England)

  3. SGLT2 inhibitors lower the risk of gout in humans.

    “sodium-glucose cotransporter-2 inhibitors which reduce serum uric acid and lowers gout risk alongside glycaemic control”

    Review

    Concurrent management of gout and type 2 diabetes mellitus: combined therapy insights

    Diabetes research and clinical practice

More on SGLT2 inhibitors

Osteoporosis

upin humans3RR 1.25

3 studies
  1. Gout is associated with osteoporosis in humans (Korean population; adjusted analysis) (11% higher development; 95% CI 1.02–1.20).

    “After adjustment, the gout group presented an 11% higher development of osteoporosis (95% confidence interval = 1.02−1.20) than the controls (p = 0.011).”

    HumansKorean population; adjusted analysis

    Potential Association of Osteoporosis and Not Osteoporotic Fractures in Patients with Gout: A Longitudinal Follow-Up Study

    Nutrients

  2. Gout is associated with osteoporosis in humans (gout compared with no history of gout or use of gout medication) (HR 1.48, 95% CI 1.45–1.51).

    “Gout showed an increased hazard ratio of 1.48 (95% CI: 1.45-1.51, P < .001).”

    Humansgout compared with no history of gout or use of gout medicationn = 305,810

    Gout as a risk factor for osteoporosis: A Korean population-based study

    Medicine

  3. Gout is associated with osteoporosis in humans (RR 1.25, 95% CI 1.05–1.48).

    “An independent population sample of four studies validated the significant association between gout and osteoporosis (RR = 1.25, 95% confidence interval [CI] 1.05-1.48)”

    Review

    Association between gout and the risk of osteoporosis and fractures: a meta-analysis

    Zeitschrift fur Rheumatologie

More on Osteoporosis

Chronic kidney disease

upin humans2HR 5.61

2 studies
  1. Chronic kidney disease is associated with gout in humans (southern provinces, association rule mining) (lift 2.60; confidence 26.14%; support 1.18%).

    “CKD→gout, support=1.18%, confidence=26.14%, lift=2.60”

    Humanssouthern provinces, association rule mining

    North-South Disparities in Multimorbidity Revealed by Association Rule and Sequential Pattern Mining: Evidence from the China National Health Survey (CNHS)

    Journal of epidemiology

  2. Gout is linked with a higher risk of chronic kidney disease in humans (HR 5.61, 95% CI 4.45-7.07).

    “CKD (5.61, 4.45-7.07)”

    Humansn = 512,724

    Hyperuricemia, gout and the associated comorbidities in China: findings from a prospective study of 0.5 million adults

    The Lancet regional health. Western Pacific

More on Chronic kidney disease

Frailty index

upin humans1upin silico1OR 2.29–2.45

2 studies
  1. Frailty index is linked with a higher risk of gout in humans (OR = 2.29, 95% CI = 1.45-3.62).

    “MR analysis confirmed a causal link between frailty index and gout (OR = 2.29, 95% CI = 1.45-3.62, P < .001)”

    Humans

    Association between frailty and gout in middle-aged and older adults: A nationwide cross-sectional and Mendelian randomization study

    Medicine

  2. Frailty index raises the risk of gout in silico (OR = 2.45, 95% CI: 1.29-4.64).

    “gout (OR = 2.45; 95% CI: 1.29-4.64; p = 0.006)”

    In silico

    Genetically Predicted Frailty Index Is Associated With Increased Risk of Multiple Metabolic Diseases: 175 226 European Participants in a Mendelian Randomization Study

    Journal of diabetes

More on Frailty index

Frailty

upin humans2OR 4.11

2 studies
  1. Frailty is associated with gout in humans (OR = 4.11, 95% CI = 3.16-5.35).

    “frail OR = 4.11, 95% CI = 3.16-5.35, P < .0001”

    Humansn = 22,324

    Association between frailty and gout in middle-aged and older adults: A nationwide cross-sectional and Mendelian randomization study

    Medicine

  2. Gout is associated with frailty in humans (patients undergoing cardiac surgery).

    “The significant predictors of prefrailty and frailty included unemployment, the presence of gout, higher New York Heart Association classes, less independence in activities of daily living, lower hemoglobin levels, and higher levels of depression.”

    Humanspatients undergoing cardiac surgery3 monthsn = 154

    Factors Associated With Frailty in Patients Undergoing Cardiac Surgery: A Longitudinal Study

    The Journal of cardiovascular nursing

Parkinson's disease

downin humans1no changein humans1HR 0.77–1

2 studies
  1. Gout is associated with Parkinson's disease in humans (Gout cases compared with population non-gout controls in western Sweden) (HR 0.77, 95% CI 0.69–0.86).

    “Cox regression also showed a significant decreased risk for PD in the gout patients”

    HumansGout cases compared with population non-gout controls in western Sweden2001–2016

    Association between gout, hyperuricaemia and Parkinson's disease risk: a cohort study in western Sweden (2001-2017)

    Rheumatology advances in practice

  2. Gout is associated with Parkinson's disease in humans (Univariate analysis) (HR 1.00, 95% CI 0.91–1.10; p = 0.935).

    “No association between gout and PD was identified in univariate analysis (HR = 1.00, 95% CI: 0.91-1.10, p = 0.935).”

    HumansUnivariate analysis

    Clinical Association between Gout and Parkinson's Disease: A Nationwide Population-Based Cohort Study in Korea

    Medicina (Kaunas, Lithuania)

More on Parkinson's disease

Age-related macular degeneration

upin humans2RR 2.73

2 studies
  1. Gout is linked with a higher risk of age-related macular degeneration in humans (RR 2.73, 95% CI 2.30-3.25, P < 0.001).

    “Patients with gout had an increased risk of developing dry AMD (relative risk, 2.73, 95% confidence intervals, 2.30-3.25; P < 0.001)”

    Humans5 years

    GOUT AND RISK OF AGE-RELATED MACULAR DEGENERATION

    Retina (Philadelphia, Pa.)

  2. Gout is linked with a higher risk of age-related macular degeneration in humans (adjusted HR 1.20, crude HR 1.55).

    “In conclusion, gout is a risk factor for developing AMD”

    Humans

    Gout as a Risk Factor for Age-Related Macular Degeneration in Taiwanese Adults-A Population-Based Study in Taiwan

    International journal of environmental research and public health

More on Age-related macular degeneration

Comprehensive nursing intervention

downin humans1

1 study
  1. Comprehensive nursing intervention lowers the risk of gout in humans.

    “The proportion of patients in the experimental group who developed gout was significantly lower than that in the control group (p=0.03).”

    Human trialtwo years

    Analysis of clinical efficacy of comprehensive nursing intervention on elderly patients with hypertension combined with hyperuricemia

    Pakistan journal of medical sciences

  2. Comprehensive nursing intervention lowers the risk of gout in elderly patients with hypertension combined with hyperuricemia (p=0.03).

    “The proportion of patients in the experimental group who developed gout was significantly lower than that in the control group(p=0.03).”

    Human trialin elderly patients with hypertension combined with hyperuricemia

    Analysis of clinical efficacy of comprehensive nursing intervention on elderly patients with hypertension combined with hyperuricemia

    Pakistan journal of medical sciences

More on Comprehensive nursing intervention

Heart failure

upin humans1HR 1.72

1 study
  1. Gout is associated with heart failure in humans (Primary pooled analysis comparing adults with and without gout) (HR 1.72, 95% CI 1.51–1.94).

    “1.72 (1.51–1.94) for heart failure”

    ReviewPrimary pooled analysis comparing adults with and without gout

    Association between gout and risk of cardiovascular outcomes: a systematic review and meta-analysis of cohort studies

    Frontiers in medicine

More on Heart failure

All 63

Trial sponsors

Funding

4 grants since 2016

National Institute of Arthritis and Musculoskeletal and Skin Diseases$3MZonMw

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Human studies link gout with accelerated biological aging, frailty, slower walking, and higher cardiovascular disease and mortality risk. Parkinson’s disease associations differ: human cohorts report lower risk or no clear link, while a review describes higher risk in women. A human trial reports fewer gout cases with a comprehensive nursing intervention in older patients with hypertension and hyperuricemia.

  2. Summary rewritten as its findings changed.

    As it read before

    Human studies link gout with accelerated biological aging and cardiovascular disease; a cohort also associates it with higher mortality and chronic kidney disease risk. Cognitive associations differ: one study links gout with lower odds of cognitive impairment, another with more subjective cognitive decline. A human trial reports reduced gout risk with comprehensive nursing in older patients with hypertension and hyperuricemia.

  3. Summary rewritten as its findings changed.

    As it read before

    In humans, biological aging and advanced PhenoAge or KDMAge predict a higher risk of gout. Separately, a review describes SGLT2 inhibitors lowering gout risk in patients with type 2 diabetes mellitus.

  4. Summary written from the findings.

Latest

Dec 2025: 6Jan 2026: 5Feb 2026: 7Mar 2026: 9Apr 2026: 2May 2026: 5Jun 2026: 3Jul 2026: 9Aug 2026: 6Sep 2026: 2Oct 2026: 10Nov 2026: 1074 papers in 12 months
Nephrology

Six genetic sites linked to kidney function decline in Taiwan

A genetic study of over 110,000 Taiwanese adults linked six of 68 identified DNA sites to kidney function decline in participants with follow-up data.A genetic study of over 110,000 Taiwanese adults linked six of 68 identified DNA sites to kidney function decline in participants with follow-up data.

Genetic association · 28,426 peopleKidney

See all 154 papers on gout